|
gptkbp:instance_of
|
gptkb:species
|
|
gptkbp:cause
|
malaria
|
|
gptkbp:diagnosis
|
blood smear
rapid diagnostic tests
|
|
gptkbp:discovered_by
|
gptkb:Sir_Ronald_Ross
|
|
gptkbp:discovery_year
|
1880
|
|
gptkbp:geographic_distribution
|
tropical regions
subtropical regions
|
|
gptkbp:hosts
|
gptkb:humans
primates
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Plasmodium vivax
|
|
gptkbp:impact
|
public health
mortality
morbidity
economic burden
|
|
gptkbp:is_a
|
species of Plasmodium
|
|
gptkbp:life_cycle
|
gptkb:sexual_reproduction
asexual reproduction
|
|
gptkbp:number_of_chromosomes
|
gptkb:14
|
|
gptkbp:prevention
|
insecticide-treated nets
antimalarial prophylaxis
indoor spraying
|
|
gptkbp:relapse
|
hypnozoites
|
|
gptkbp:relapse_frequency
|
up to 80%
|
|
gptkbp:related_to
|
gptkb:Plasmodium_falciparum
gptkb:Plasmodium_malariae
gptkb:Plasmodium_ovale
|
|
gptkbp:research_focus
|
genetic studies
treatment efficacy
vaccine development
|
|
gptkbp:seed_dispersal
|
23 million base pairs
|
|
gptkbp:symptoms
|
fatigue
headache
muscle pain
nausea
fever
vomiting
48 hours
chills
sweats
|
|
gptkbp:transmission
|
mosquito bites
|
|
gptkbp:treatment
|
gptkb:chloroquine
gptkb:primaquine
antimalarial drugs
|
|
gptkbp:vector
|
gptkb:Anopheles_mosquitoes
|
|
gptkbp:water_resistance
|
chloroquine resistance
primaquine resistance
|
|
gptkbp:bfsParent
|
gptkb:artemisinin-based_therapies
gptkb:Plasmodium
|
|
gptkbp:bfsLayer
|
7
|